Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga January 09, 2015 at 08:09 AM EST Conatus Pharmaceuticals Inc (NASDAQ: CNAT) shares dropped 41.05% to $6.09 in pre-market trading after the company reported top-line ... Read More >> Related Stocks: Conatus Pharmaceutic Five Below Inc Golar Lng Ltd Golar Lng Partners